课题基金 / 基金详情

项目摘要

项目成果

Charles M Brenner的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Liver is the primary site of alcohol metabolism and is the primary organ that is injured by alcohol. Though it has long been clear that ethanol is metabolized to acetate in hepatocytes, it is known that the acetate isn't burned as fuel in the liver or directly converted to fat in the liver. The knowledge that the calories from ethanol are burned in the muscle may have inhibited people from considering whether any further metabolism of acetate occurs in the liver and whether this could be linked to alcohol hepatopathology. Recently, liver mitochondrial protein acetylation has been described in response to alcohol ingestion. This means that liver mitochondrial proteins are tagged with the exact same molecule that liver produces when we drink alcohol. We also know from genetics that many mitochondrial proteins with the acetylation tag are inhibited by this adduct and that mice that have this modification accumulate in mitochondrial proteins get fatty liver. In this proposal, a straightforward mechanism from ethanol to acetylated liver mitochondrial proteins is proposed and will be tested. Moreover, nicotinamide riboside, a vitamin that has the property of increasing NAD+ in mitochondria, is proposed as an agent to protect against the development of alcohol-derived mitochondrial protein hyperacetylation and alcoholic fatty liver.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Evaluating NAD Supplementation as a Novel Treatment for Arrhythmias
  • 批准号:
    9765003
  • 项目类别:
  • 资助金额:
    $60.59万
  • 财政年份:
    2019
  • 负责人:
    Charles M Brenner
  • 依托单位:
Evaluating NAD Supplementation as a Novel Treatment for Arrhythmias
  • 批准号:
    10381462
  • 项目类别:
  • 资助金额:
    $58.26万
  • 财政年份:
    2019
  • 负责人:
    Charles M Brenner
  • 依托单位:
Evaluating NAD Supplementation as a Novel Treatment for Arrhythmias
  • 批准号:
    10671263
  • 项目类别:
  • 资助金额:
    $12.32万
  • 财政年份:
    2019
  • 负责人:
    Charles M Brenner
  • 依托单位:
Evaluating NAD Supplementation as a Novel Treatment for Arrhythmias
  • 批准号:
    9889991
  • 项目类别:
  • 资助金额:
    $59.16万
  • 财政年份:
    2019
  • 负责人:
    Charles M Brenner
  • 依托单位:
海外基金